Cytogarde
Delivering peace of mind
CytoGarde is a testing regimen used to verify cytocompatibility of Cook Regentec devices.*
Viability
Viability
Viability
Recovery
Viability
Functionality
Viability

Viability

Viability

Recovery

Viability

Functionality

While verification does not guarantee a device is cytocompatible with all cell types and clinical applications, CytoGarde is intended to provide the clinician peace of mind that a device bearing the CytoGarde insignia verifies that the device has been designed and tested for cell delivery applications.
Cell therapy is a growing area of interest in clinical practice. Advances in cell therapy are increasing the number of options addressing a spectrum of challenging medical conditions. There has also been a corresponding increase in the number and types of methods for delivering these therapies to patients. Ideally, these devices should be cytocompatible, i.e., have minimal to no adverse impact on the cell therapy on delivery.
CytoGarde follows the guidelines delineated in ASTM F3206 – 17* in testing for recovery, viability and functionality of clinically relevant cell types.
CytoGarde Verified Devices available through Cook Regentec include:
*ASTM F3206 – 17 (Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies) cytocompatibility is defined as: “the lack of unacceptable impact on a cellular product from interaction with a medical device used for delivery or interaction with manufacturing components.